Trends in Volumes and Survival After Hematopoietic Cell Transplantation in Racial/Ethnic Minorities.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
25 Apr 2024
Historique:
accepted: 27 02 2024
received: 19 12 2023
revised: 23 02 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 25 4 2024
Statut: aheadofprint

Résumé

There has been an increase in volume as well as improvement in overall survival (OS) after hematopoietic cell transplantation (HCT) for hematologic disorders. It is unknown if these changes have impacted racial/ethnic minorities equally. In this observational study from Center for International Blood and Marrow Transplant Research of 79,904 autologous (auto) and 65,662 allogeneic (allo) HCTs, we examined the volume and rates of change of auto HCT and allo HCT over time and trends in OS in 4 racial/ethnic groups: Non-Hispanic Whites (NHWs), Non-Hispanic African Americans (NHAAs), Hispanics across five 2-year cohorts from 2009 to 2018. Rates of change were compared using Poisson model. Adjusted and unadjusted Cox proportional hazards models examined trends in mortality in the 4 racial/ethnic groups over 5 study time periods. The rates of increase in volume were significantly higher for Hispanics and NHAAs vs. NHW for both autoHCT and alloHCT. Adjusted overall mortality after autoHCT was comparable across all racial/ethnic groups. NHAA adults (HR 1.13; 95% CI 1.04-1.22; p=0.004) and pediatric patients (HR 1.62; 95% CI 1.3-2.03; p<0.001 had a higher risk of mortality after alloHCT compared to NHWs. Improvement in OS over time was seen in all 4 groups after both autoHCT and alloHCT.Our study shows the rate of change for the use of autoHCT and alloHCT is higher in NHAAs and Hispanics compared to NHWs. Survival after autoHCT and alloHCT improved over time, however NHAAs have worse OS after alloHCT which has persisted. Continued efforts are needed to mitigate disparities for patients requiring alloHCT.

Identifiants

pubmed: 38661372
pii: 515893
doi: 10.1182/bloodadvances.2023012469
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society of Hematology.

Auteurs

Nandita Khera (N)

Mayo Clinic in Arizona, Phoenix, Arizona, United States.

Sikander Ailawadhi (S)

Mayo Clinic, Jacksonville, Florida, United States.

Ruta Brazauskas (R)

Center for International Blood and Marrow Transplant Research (CIBMTR), United States.

Jinalben Patel (J)

Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, Wisconsin, United States.

Benjamin Jacobs (B)

Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, Wisconsin, United States.

Celalettin Ustun (C)

Rush University, Chicago, Illinois, United States.

Karen Ballen (K)

University of Virginia Health, Charlottesville, Virginia, United States.

Muhammad Bilal Abid (MB)

Medical College of Wisconsin, Wauwatosa, Wisconsin, United States.

Miguel A Díaz (MA)

HOSPITAL NiÑO JESUS, MADRID, Spain.

A Samar Al-Homsi (AS)

New York University Langone Medical Center, New York, New York, United States.

Hasan Hashem (H)

King Hussein Cancer Center, Amman, Jordan.

Sanghee Hong (S)

Duke University School of Medicine, Durham, North Carolina, United States.

Reinhold Munker (R)

University of Kentucky, Lexington, Kentucky, United States.

Raquel Schears (R)

University of Central Florida, Rochester, Minnesota, United States.

Hillard M Lazarus (HM)

Case Western Reserve University, Cleveland, Ohio, United States.

Stefan O Ciurea (SO)

University of California, Irvine, Orange, California, United States.

Sherif M Badawy (SM)

Northwestern University Feinberg School of Medicine, United States.

Bipin N Savani (BN)

Vanderbilt University Medical Center, Nashville, Tennessee, United States.

Baldeep Wirk (B)

Virginia Commonwealth University Medical Center, Richmond, Virginia, United States.

Charles F LeMaistre (CF)

Sarah Cannon Cancer Institute, Nashville, Tennessee, United States.

Neel S Bhatt (NS)

University of Washington School of Medicine, United States.

Amer Beitinjaneh (A)

University of Miami Health System, Miami, Florida, United States.

Mahmoud Aljurf (M)

King Faisal Specialist Hospital, Riyadh, Saudi Arabia.

Akshay Sharma (A)

St Jude Children's Research Hospital, Memphis, Tennessee, United States.

Jan Cerny (J)

University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States.

Jennifer M Knight (JM)

Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Amar H Kelkar (AH)

Dana-Farber Cancer Institute, Boston, Massachusetts, United States.

Jean A Yared (JA)

University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, United States.

Tamila Kindwall-Keller (T)

MetroHealth System, Cleveland, Ohio, United States.

Lena E Winestone (LE)

University of California San Francisco Benioff Children's Hospitals, San Fransisco, California, United States.

Amir Steinberg (A)

Westchester Medical Center, Hawthorne, New York, United States.

Staci D Arnold (SD)

Emory University, Atlanta, Georgia, United States.

Sachiko Seo (S)

Dokkyo Medical University, Tochigi, Japan.

Jaime M Preussler (JM)

CIBMTR (Center for International Blood and Marrow Transplant Research) & NMDP, Minneapolis, Minnesota, United States.

Nasheed M Hossain (NM)

University of Pennsylvania, Philadelphia, Pennsylvania, United States.

Warren B Fingrut (WB)

Harvard T.H. Chan School of Public Health, United States.

Vaibhav Agrawal (V)

City of Hope National Medical Center, Duarte, California, United States.

Shahrukh Hashmi (S)

Sheikh Shakhbout Medical City; Khalifa University, United Arab Emirates.

Leslie Elaine Lehmann (LE)

Dana-Farber Cancer Institute / Children's Hospital, Boston, Boston, Massachusetts, United States.

William A Wood (WA)

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.

Hemalatha G Rangarajan (HG)

Nationwide Childrens Hosptial, Columbus, Ohio, United States.

Wael Saber (W)

Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Theresa Hahn (T)

Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States.

Classifications MeSH